HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David G McCormack Selected Research

Helium

1/2020Pulmonary Imaging Phenotypes of Chronic Obstructive Pulmonary Disease Using Multiparametric Response Maps.
10/2019Hyperpolarized Helium 3 MRI in Mild-to-Moderate Asthma: Prediction of Postbronchodilator Reversibility.
1/2018Free-breathing Pulmonary MR Imaging to Quantify Regional Ventilation.
12/2015COPD: Do Imaging Measurements of Emphysema and Airway Disease Explain Symptoms and Exercise Capacity?
11/2012Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease.
10/2011Chronic obstructive pulmonary disease: quantification of bronchodilator effects by using hyperpolarized ³He MR imaging.
7/2010Chronic obstructive pulmonary disease: longitudinal hyperpolarized (3)He MR imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David G McCormack Research Topics

Disease

24Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 05/2005
11Emphysema
01/2020 - 01/2012
10Asthma (Bronchial Asthma)
11/2022 - 12/2010
5Sepsis (Septicemia)
06/2005 - 04/2002
5Pneumonia (Pneumonitis)
06/2004 - 04/2002
4Acute Lung Injury
06/2005 - 04/2002
3Disease Progression
11/2017 - 09/2014
2Obstructive Lung Diseases (Obstructive Lung Disease)
01/2019 - 08/2014
2Fibrosis (Cirrhosis)
01/2017 - 04/2005
1Lung Diseases (Lung Disease)
04/2018
1Pulmonary Emphysema
11/2017
1Bronchiectasis
01/2017
1Dyspnea (Shortness of Breath)
08/2014
1Cystic Fibrosis (Mucoviscidosis)
12/2010
1Lung Injury
12/2010
1Bronchogenic Carcinoma
05/2010
1Lung Neoplasms (Lung Cancer)
05/2010
1Infections
06/2004
1Respiratory Insufficiency (Respiratory Failure)
06/2002

Drug/Important Bio-Agent (IBA)

8Carbon MonoxideIBA
11/2017 - 11/2012
7HeliumIBA
01/2020 - 07/2010
7GoldIBA
01/2020 - 08/2008
7Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2014 - 04/2002
6Bronchodilator Agents (Bronchodilators)IBA
11/2022 - 10/2011
6Biomarkers (Surrogate Marker)IBA
11/2022 - 05/2016
6Helium-3IBA
08/2013 - 12/2010
6Proteins (Proteins, Gene)FDA Link
06/2005 - 04/2002
4Albuterol (Salbutamol)FDA LinkGeneric
10/2017 - 10/2011
4Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2005 - 05/2002
4Nitric Oxide Synthase (NO Synthase)IBA
08/2004 - 04/2002
3HydrogenIBA
01/2018 - 07/2010
3Peroxidase (Myeloperoxidase)IBA
06/2005 - 04/2002
2Methacholine Chloride (Methacholine)FDA Link
10/2017 - 01/2014
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2004 - 11/2003
2Arachidonic Acid (Vitamin F)IBA
06/2004 - 11/2003
2EnzymesIBA
11/2003 - 05/2002
1Contrast MediaIBA
01/2018
1Clostridium perfringens epsilon-toxinIBA
08/2014
1Tobacco Smoke Pollution (Passive Smoking)IBA
08/2014
1Complement System Proteins (Complement)IBA
01/2014
1N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA
05/2013
1Xenon-129IBA
03/2013
1XenonIBA
11/2012
1Radioisotopes (Radionuclides)IBA
05/2010
1Tyrosine (L-Tyrosine)FDA Link
06/2005
13-nitrotyrosineIBA
06/2005
1IsoprostanesIBA
06/2005
1Oxidants (Oxidizing Agents)IBA
06/2005
1Pergolide (Permax)FDA Link
04/2005
120-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
11/2003
1AcidsIBA
11/2003
1salicylhydroxamic acid (SHAM)IBA
12/2002
1DEET (DET)IBA
12/2002
11- hydroxy- 2- oxo- 3,3- bis(2- aminoethyl)- 1- triazeneIBA
12/2002
1Glyburide (Glibenclamide)FDA LinkGeneric
09/2002
14-Aminopyridine (4 Aminopyridine)FDA Link
09/2002
1Delayed Rectifier Potassium ChannelsIBA
09/2002
1Adenosine Triphosphate (ATP)IBA
09/2002
1Prostaglandins FIBA
09/2002
1paxillineIBA
09/2002
1Phenylephrine (Neo-Synephrine)FDA LinkGeneric
09/2002
1Tetraethylammonium (Tetraethylammonium Bromide)IBA
09/2002
1CalciumIBA
06/2002
1Coloring Agents (Dyes)IBA
06/2002
1Evans Blue (Blue, Evans)FDA Link
06/2002
1pimagedine (aminoguanidine)IBA
05/2002
18-epi-prostaglandin F2alphaIBA
04/2002

Therapy/Procedure

8Therapeutics
11/2017 - 05/2005
4Ligation
06/2005 - 04/2002
2Positive-Pressure Respiration (Positive End-Expiratory Pressure)
05/2005 - 06/2002
1Bronchial Thermoplasty
07/2021
1Pneumonectomy (Lung Volume Reduction)
01/2018
1Stents
01/2012
1Transplantation
12/2010
1Length of Stay
05/2005
1Aftercare (After-Treatment)
09/2002
1Investigational Therapies (Experimental Therapy)
09/2002